Mathematical modeling of G2/M phase in the cell cycle with involving the p53/Mdm2 oscillation system

Yoshihiko Tashima, Yu Kisaka, Taizo Hanai, Hiroyuki Hamada, Yukihiro Eguchi, Masahiro Okamoto

研究成果: ジャーナルへの寄稿Conference article

3 引用 (Scopus)

抄録

In the cell cycle, the disruption of a checkpoint control mechanism for G2/M phase which monitors DNA damages is one of the triggers for oncogenic transformation. The major event of this mechanism is the p53/Mdm2 signaling pathway-mediated repression of M-phase Promoting Factor (MPF) activation. With the occurring some DNA damages, the protein levels of the p53/Mdm2 shows the oscillation, and the temporal response of the MPF activation delays. However, the detailed interactions between the p53/Mdm2 oscillation and the MPF activation are still unclear biologically. In this study, we designed a mathematical model which can realize the qualitative temporal dynamics of G2/M phase involving the p53/Mdm2 signaling pathway. Moreover we performed some simulations and comprehensive system analysis in order to evaluate the robustness and to explore the dominant control factors of the model. A novel mathematical model (proposed model) was designed by integrating a model for the MPF activation with the p53/Mdm2 signaling pathway. The numerical solutions of the dynamics with employing the proposed model showed the qualitative correspondence with the p53/Mdm2 oscillation and the temporal delay of the MPF activation, which were observed experimentally. Without the assumption of DNA damage, the sensitivity of kinetic parameters of this model was low, and the model system showed high stability. In the case of some DNA damages, however, the sensitivity became to be higher, and the model system showed instability. Thus, we can evaluate that some DNA damages can easily affect the stability of the checkpoint control mechanism. A defective function of Wee1 phosphorylation which affects the dynamics of MPF inhibited the DNA damagemediated temporal delay of the MPF activation. Since a chronic decline of protein level for Wee1 was observed in tumor cells, we proposed that the phosphorylation is one of the dominant factors for the checkpoint control mechanism in G2/M phase.

元の言語英語
ページ(範囲)197-200
ページ数4
ジャーナルIFMBE Proceedings
14
発行部数1
出版物ステータス出版済み - 1 1 2007
イベント10th World Congress on Medical Physics and Biomedical Engineering, WC 2006 - Seoul, 大韓民国
継続期間: 8 27 20069 1 2006

Fingerprint

Maturation-Promoting Factor
oscillation
Cells
DNA
Chemical activation
modeling
Phosphorylation
damage
Mathematical models
Proteins
Kinetic parameters
protein
Tumors
systems analysis
tumor
Systems analysis

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Biomedical Engineering

これを引用

Mathematical modeling of G2/M phase in the cell cycle with involving the p53/Mdm2 oscillation system. / Tashima, Yoshihiko; Kisaka, Yu; Hanai, Taizo; Hamada, Hiroyuki; Eguchi, Yukihiro; Okamoto, Masahiro.

:: IFMBE Proceedings, 巻 14, 番号 1, 01.01.2007, p. 197-200.

研究成果: ジャーナルへの寄稿Conference article

Tashima, Yoshihiko ; Kisaka, Yu ; Hanai, Taizo ; Hamada, Hiroyuki ; Eguchi, Yukihiro ; Okamoto, Masahiro. / Mathematical modeling of G2/M phase in the cell cycle with involving the p53/Mdm2 oscillation system. :: IFMBE Proceedings. 2007 ; 巻 14, 番号 1. pp. 197-200.
@article{c791f3d0682147f39d198518531aaca7,
title = "Mathematical modeling of G2/M phase in the cell cycle with involving the p53/Mdm2 oscillation system",
abstract = "In the cell cycle, the disruption of a checkpoint control mechanism for G2/M phase which monitors DNA damages is one of the triggers for oncogenic transformation. The major event of this mechanism is the p53/Mdm2 signaling pathway-mediated repression of M-phase Promoting Factor (MPF) activation. With the occurring some DNA damages, the protein levels of the p53/Mdm2 shows the oscillation, and the temporal response of the MPF activation delays. However, the detailed interactions between the p53/Mdm2 oscillation and the MPF activation are still unclear biologically. In this study, we designed a mathematical model which can realize the qualitative temporal dynamics of G2/M phase involving the p53/Mdm2 signaling pathway. Moreover we performed some simulations and comprehensive system analysis in order to evaluate the robustness and to explore the dominant control factors of the model. A novel mathematical model (proposed model) was designed by integrating a model for the MPF activation with the p53/Mdm2 signaling pathway. The numerical solutions of the dynamics with employing the proposed model showed the qualitative correspondence with the p53/Mdm2 oscillation and the temporal delay of the MPF activation, which were observed experimentally. Without the assumption of DNA damage, the sensitivity of kinetic parameters of this model was low, and the model system showed high stability. In the case of some DNA damages, however, the sensitivity became to be higher, and the model system showed instability. Thus, we can evaluate that some DNA damages can easily affect the stability of the checkpoint control mechanism. A defective function of Wee1 phosphorylation which affects the dynamics of MPF inhibited the DNA damagemediated temporal delay of the MPF activation. Since a chronic decline of protein level for Wee1 was observed in tumor cells, we proposed that the phosphorylation is one of the dominant factors for the checkpoint control mechanism in G2/M phase.",
author = "Yoshihiko Tashima and Yu Kisaka and Taizo Hanai and Hiroyuki Hamada and Yukihiro Eguchi and Masahiro Okamoto",
year = "2007",
month = "1",
day = "1",
language = "English",
volume = "14",
pages = "197--200",
journal = "IFMBE Proceedings",
issn = "1680-0737",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Mathematical modeling of G2/M phase in the cell cycle with involving the p53/Mdm2 oscillation system

AU - Tashima, Yoshihiko

AU - Kisaka, Yu

AU - Hanai, Taizo

AU - Hamada, Hiroyuki

AU - Eguchi, Yukihiro

AU - Okamoto, Masahiro

PY - 2007/1/1

Y1 - 2007/1/1

N2 - In the cell cycle, the disruption of a checkpoint control mechanism for G2/M phase which monitors DNA damages is one of the triggers for oncogenic transformation. The major event of this mechanism is the p53/Mdm2 signaling pathway-mediated repression of M-phase Promoting Factor (MPF) activation. With the occurring some DNA damages, the protein levels of the p53/Mdm2 shows the oscillation, and the temporal response of the MPF activation delays. However, the detailed interactions between the p53/Mdm2 oscillation and the MPF activation are still unclear biologically. In this study, we designed a mathematical model which can realize the qualitative temporal dynamics of G2/M phase involving the p53/Mdm2 signaling pathway. Moreover we performed some simulations and comprehensive system analysis in order to evaluate the robustness and to explore the dominant control factors of the model. A novel mathematical model (proposed model) was designed by integrating a model for the MPF activation with the p53/Mdm2 signaling pathway. The numerical solutions of the dynamics with employing the proposed model showed the qualitative correspondence with the p53/Mdm2 oscillation and the temporal delay of the MPF activation, which were observed experimentally. Without the assumption of DNA damage, the sensitivity of kinetic parameters of this model was low, and the model system showed high stability. In the case of some DNA damages, however, the sensitivity became to be higher, and the model system showed instability. Thus, we can evaluate that some DNA damages can easily affect the stability of the checkpoint control mechanism. A defective function of Wee1 phosphorylation which affects the dynamics of MPF inhibited the DNA damagemediated temporal delay of the MPF activation. Since a chronic decline of protein level for Wee1 was observed in tumor cells, we proposed that the phosphorylation is one of the dominant factors for the checkpoint control mechanism in G2/M phase.

AB - In the cell cycle, the disruption of a checkpoint control mechanism for G2/M phase which monitors DNA damages is one of the triggers for oncogenic transformation. The major event of this mechanism is the p53/Mdm2 signaling pathway-mediated repression of M-phase Promoting Factor (MPF) activation. With the occurring some DNA damages, the protein levels of the p53/Mdm2 shows the oscillation, and the temporal response of the MPF activation delays. However, the detailed interactions between the p53/Mdm2 oscillation and the MPF activation are still unclear biologically. In this study, we designed a mathematical model which can realize the qualitative temporal dynamics of G2/M phase involving the p53/Mdm2 signaling pathway. Moreover we performed some simulations and comprehensive system analysis in order to evaluate the robustness and to explore the dominant control factors of the model. A novel mathematical model (proposed model) was designed by integrating a model for the MPF activation with the p53/Mdm2 signaling pathway. The numerical solutions of the dynamics with employing the proposed model showed the qualitative correspondence with the p53/Mdm2 oscillation and the temporal delay of the MPF activation, which were observed experimentally. Without the assumption of DNA damage, the sensitivity of kinetic parameters of this model was low, and the model system showed high stability. In the case of some DNA damages, however, the sensitivity became to be higher, and the model system showed instability. Thus, we can evaluate that some DNA damages can easily affect the stability of the checkpoint control mechanism. A defective function of Wee1 phosphorylation which affects the dynamics of MPF inhibited the DNA damagemediated temporal delay of the MPF activation. Since a chronic decline of protein level for Wee1 was observed in tumor cells, we proposed that the phosphorylation is one of the dominant factors for the checkpoint control mechanism in G2/M phase.

UR - http://www.scopus.com/inward/record.url?scp=84887263481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887263481&partnerID=8YFLogxK

M3 - Conference article

VL - 14

SP - 197

EP - 200

JO - IFMBE Proceedings

JF - IFMBE Proceedings

SN - 1680-0737

IS - 1

ER -